๐Ÿ”ฌDeep Research

ABBV โ€” AbbVie ยท catalysts, narrative & risks

ยท23 sourcesABBV forecast โ†’

Quick Snapshot (as of 2026-10-03)

AbbVie (NYSE:ABBV) is a Chicago-based biopharmaceutical company. In early October 2026 the stock trades in the low-$260s โ€” Yahoo Finance shows a previous close of $259.93 with a day range of $257.87โ€“$264.06, and another quote places it near $263.61, up ~18% year-to-date โ€” with a market cap of roughly $464B and a 52-week range of $190.75โ€“$269.39 [20]. A 1-year analyst price target sits around $278.86 [20]. The company pays a forward dividend on the order of $6.83โ€“$6.92 per share (about a 2.66% yield) [2][20].


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’